Loading
Journal of Experimental Nephrology
ISSN: 2767-3383
Volume 3, Issue 1, p1-8
Articles published in this issue are Open Access and licensed under Creative Commons Attribution License (CC BY NC) where the readers can reuse, download, distribute the article in whole or part by mentioning proper credits to the authors.
An update on proliferative glomerulonephritis with monoclonal immunoglobulin deposits in pediatric patients
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) was first described by Nasr et al. in 2004 with a subsequent study composed of a larger patient cohort a few years later [1,2]. Although more commonly occurring in older adults, PGNMID has since been reported in a wide range of age groups including children [3-5]. PGNMID is categorized as a monoclonal gammopathy of renal significance (MGRS), and is additionally included in the recently expanded concept of monoclonal gammopathy of clinical significance (MGCS), which encompasses disorders of any organ system related to underlying plasma cell or B-cell clones [6]; however, most patients with PGNMID do not show evidence of a circulating monoclonal protein or clonal plasma cell proliferation, and monoclonal gammopathy has not been reported in any pediatric patients with the disease. Herein we briefly discuss the clinical and histopathologic features of PGNMID, as well as advances in our understanding of the pathogenesis and clinical course of the disease.
J Exp Nephrol, 2022, Volume 3, Issue 1, p1-4 | DOI: 10.46439/nephrology.3.11
Role of vitamin D in diabetic nephropathy
Diabetic nephropathy (DN) or Diabetic kidney disease (DKD) is one of the major microvascular complications of diabetes mellitus (DM). DN is observed in approximately 20–40% of diabetic patients. DN is also an important risk factor for DM patient’s death. Nowadays, DN has become the leading cause of chronic renal failure (CRF) in most countries without effective therapeutic methods. Recently, the renoprotective effects mediated by vitamin D have been evidenced. Currently available evidence showed that vitamin D is effective in reducing proteinuria in DN patients. A recent meta-analysis demonstrated the therapeutic effect of vitamin D, on urinary albumin excretion, in DN patients. This review summarized the multiple roles of vitamin D in mechanism of renopretective effect of vitamin D to explore much more and effective therapeutic methods for DN.
J Exp Nephrol, 2022, Volume 3, Issue 1, p5-8 | DOI: 10.46439/nephrology.3.012
Glucan and Vitamin D supplementation showed synergy in improvements of the immune response against an influenza challenge in mice
Influenza infection remains a serious health problem throughout the world. Unfortunately, current medicine offers no real treatment or protection, moving our attention to alternative options. In this study we aimed to evaluate the possible effects of a combination of glucan and vitamin C on immunosuppression caused by influenza infection.
Is vitamin D the missing link between childhood obesity and adenovirus-36 infection?
It may seem irony that nutrition science historically pertained mostly to undernutrition and deficiency syndromes [1] but nowadays prevention, control and treatment of overnutrition, manifested as overweight and obesity, has become the main task of most nutritionists and related professionals [2].
Antioxidant vitamins in diabetic kidney disease: The unsettled issues
Diabetic kidney disease (DKD), as a common complication of diabetes mellitus, is one of the leading causes for end-stage renal disease (ESRD) in the world. Inhibitors of the renin–angiotensin–aldosterone system is widely used in DKD, but many patients still progressed to ESRD, and progress in the treatment of DKD is limited in recent years, thus more effective ways to prevent or treat DKD are necessary. Chronic hyperglycemia can induce the imbalance between the excessive reactive oxygen species (ROS) and antioxidant defense mechanisms. Increasing evidences indicated oxidative stress acts as a crucial role in the initiation and progression of DKD. It is suggested that the restoration of the balance between oxidative stress and antioxidant defense may be a hopeful drug target to prevent or treat DKD. Our meta-analysis showed that the antioxidant vitamins can benefit kidney function and systolic blood pressure in patients with diabetes and albuminuria.
An update on proliferative glomerulonephritis with monoclonal immunoglobulin deposits in pediatric patients
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) was first described by Nasr et al. in 2004 with a subsequent study composed of a larger patient cohort a few years later [1,2]. Although more commonly occurring in older adults, PGNMID has since been reported in a wide range of age groups including children [3-5]. PGNMID is categorized as a monoclonal gammopathy of renal significance (MGRS), and is additionally included in the recently expanded concept of monoclonal gammopathy of clinical significance (MGCS), which encompasses disorders of any organ system related to underlying plasma cell or B-cell clones [6]; however, most patients with PGNMID do not show evidence of a circulating monoclonal protein or clonal plasma cell proliferation, and monoclonal gammopathy has not been reported in any pediatric patients with the disease. Herein we briefly discuss the clinical and histopathologic features of PGNMID, as well as advances in our understanding of the pathogenesis and clinical course of the disease.
Role of vitamin D in diabetic nephropathy
Diabetic nephropathy (DN) or Diabetic kidney disease (DKD) is one of the major microvascular complications of diabetes mellitus (DM). DN is observed in approximately 20–40% of diabetic patients. DN is also an important risk factor for DM patient’s death. Nowadays, DN has become the leading cause of chronic renal failure (CRF) in most countries without effective therapeutic methods. Recently, the renoprotective effects mediated by vitamin D have been evidenced. Currently available evidence showed that vitamin D is effective in reducing proteinuria in DN patients. A recent meta-analysis demonstrated the therapeutic effect of vitamin D, on urinary albumin excretion, in DN patients. This review summarized the multiple roles of vitamin D in mechanism of renopretective effect of vitamin D to explore much more and effective therapeutic methods for DN.
Increased incidence of severe burns in pediatric patients during the COVID -19 pandemic
During the COVID-19 pandemic, an increase in the incidence of burns in the pediatric population was observed worldwide, in our institution an increase was observed in the same way in the year 2020 and after this in the year 2021, when pandemic restrictions were continued.
Beyond single targets: Crosstalk between endoplasmic reticulum stress, ferroptosis, and vitamin D signaling in stroke treatment
Stroke remains a leading cause of death and long-term disability worldwide, with ischemic stroke representing approximately 85% of all stroke cases. Cerebral ischemia-reperfusion (I/R) injury significantly exacerbates neuronal damage through mechanisms such as oxidative stress, ferroptosis, and endoplasmic reticulum stress (ERS).